RPG Life SciencesNSE:RPGLIFE +0.92%92 Pretax Margin % is 22.73% as of Mar. 2026, which is 48% above its 10-year median of 15.36. GuruFocus rates NSE:RPGLIFE with a GF Score™ of 92/100 and a GF Value™ of ₹2,353.32 (Fairly Valued). The stock has 5 warning signs investors should review. Among 954 Drug Manufacturers companies, RPG Life Sciences ranks better than 83.75% on this metric.
The historical rank and industry rank for RPG Life Sciences's Pretax Margin % or its related term are showing as below:
NSE:RPGLIFE'
s Pretax Margin % Range Over the Past 10 Years
Min: 4.65 Med: 15.36 Max: 35.96
Current: 21.79
NSE:RPGLIFE's Pretax Margin % is ranked better than 83.75% of 954
companies
in the Drug Manufacturers industry
Industry Median: 7.295
vs NSE:RPGLIFE: 21.79
RPG Life Sciences (NSE:RPGLIFE) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
RPG Life Sciences Pretax Margin % Related Terms
RPG Life Sciences Pretax Margin % Historical Data
* Premium members only.
The historical data trend for RPG Life Sciences's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:RPGLIFE vs ZTS, UTHR: Pretax Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, RPG Life Sciences's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
RPG Life Sciences Pretax Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, RPG Life Sciences's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where RPG Life Sciences's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RPG Life Sciences (NSE:RPGLIFE) has a Pretax Margin % of 22.73% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on RPG Life Sciences and its competitors. This is 48% above median its historical median of 15.36. Over the past decade, RPG Life Sciences' Pretax Margin % has ranged from 4.65 to 35.96. According to the industry distribution chart, RPG Life Sciences ranks #155 out of 954 companies in the Drug Manufacturers industry, placing it in the top 16.2%.
Is RPG Life Sciences' Pretax Margin % too high?
RPG Life Sciences' current Pretax Margin % of 22.73% is 48% above median its 10-year median of 15.36. Over the past 10 years, this metric has ranged from a low of 4.65 to a high of 35.96. The Drug Manufacturers industry median Pretax Margin % is 7.30. RPG Life Sciences' value of 22.73% is 211.6% above this industry median. Based on the distribution chart, RPG Life Sciences ranks #155 out of 954 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, RPG Life Sciences has a GF Score™ of 92/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does RPG Life Sciences' Pretax Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, RPG Life Sciences ranks #155 out of 954 companies for Pretax Margin %. This places RPG Life Sciences in the top 16% of its industry — outperforming the majority of peers. The industry median Pretax Margin % is 7.30. RPG Life Sciences' value of 22.73% is 211.6% above this benchmark. Historically, RPG Life Sciences' own Pretax Margin % has ranged from 4.65 to 35.96 over the past decade. While the company's 10-year median is 15.36 vs. the industry median of 7.30, RPG Life Sciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.30, based on 954 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. RPG Life Sciences's current Pretax Margin % of 22.73% is 211.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on RPG Life Sciences and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. RPG Life Sciences's current Pretax Margin % is 22.73%, which is 48% above median its own 10-year median of 15.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RPG Life Sciences stock overvalued right now?
Based on GuruFocus' analysis, RPG Life Sciences (NSE:RPGLIFE) is currently considered Fairly Valued. The stock's GF Value™ is ₹2,353.32, compared to a current price of ₹2,415.80 — trading 2.7% above its estimated fair value. The current Pretax Margin % is 22.73%, which is 48% above median its 10-year median of 15.36 and 211.6% above the Drug Manufacturers industry median of 7.30. RPG Life Sciences' overall GF Score™ is 92/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For RPG Life Sciences (NSE:RPGLIFE), the current Pretax Margin % is 22.73% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is RPG Life Sciences (NSE:RPGLIFE) Overvalued in 2026?
Based on GuruFocus' analysis, RPG Life Sciences stock appears to be overvalued.
The current stock price of ₹2,415.80 is trading 2.7% above its estimated GF Value™ of ₹2,353.32.
GuruFocus considers RPG Life Sciences to be Fairly Valued.
Key valuation signals for NSE:RPGLIFE:
Pretax Margin %: 22.73% (48% above median its 10-year median of 15.36)
GF Value™: ₹2,353.32 vs. price of ₹2,415.80 (2.7% above fair value)
Industry Position: 211.6% above the Drug Manufacturers median (#155 of 954)
No single metric tells the full story. See the NSE:RPGLIFE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
RPG Life Sciences Ltd is an integrated pharmaceutical company. Its only reportable segment is the manufacturing and marketing of pharmaceutical products. Geographically, it derives a majority of revenue from India. The company operates across Domestic Formulations, International Formulations and Active Pharmaceutical Ingredients (API). It focuses on Nephrology, Oncology, Urology, Respiratory, Gastrointestinal, Cardiovascular, Gynaecology and Pediatrics, Vitamins and Minerals, Pain Management, Neurology, Anti-Dengue, Anti-Diabetic, and Derma.
92GF Score
Get the complete analysis for NSE:RPGLIFE
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:RPGLIFE has been successfully added to your 
